• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下感染模型有助于评估小鼠继发性泡型包虫病的治疗效果。

Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice.

机构信息

Institute of Parasitology, Vetsuisse Faculty, University of Berne, Berne, Switzerland.

出版信息

PLoS Negl Trop Dis. 2013 May 23;7(5):e2235. doi: 10.1371/journal.pntd.0002235. Print 2013.

DOI:10.1371/journal.pntd.0002235
PMID:23717701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3662659/
Abstract

Alveolar echinococcosis (AE) in humans is a parasitic disease characterized by severe damage to the liver and occasionally other organs. AE is caused by infection with the metacestode (larval) stage of the fox tapeworm Echinococcus multilocularis, usually infecting small rodents as natural intermediate hosts. Conventionally, human AE is chemotherapeutically treated with mebendazole or albendazole. There is, however still the need for improved chemotherapeutical options. Primary in vivo studies on drugs of interest are commonly performed in small laboratory animals such as mice and Mongolian jirds, and in most cases, a secondary infection model is used, whereby E. multilocularis metacestodes are directly injected into the peritoneal cavity or into the liver. Disadvantages of this methodological approach include risk of injury to organs during the inoculation and, most notably, a limitation in the macroscopic (visible) assessment of treatment efficacy. Thus, in order to monitor the efficacy of chemotherapeutical treatment, animals have to be euthanized and the parasite tissue dissected. In the present study, mice were infected with E. multilocularis metacestodes through the subcutaneous route and were then subjected to chemotherapy employing albendazole. Serological responses to infection were comparatively assessed in mice infected by the conventional intraperitoneal route. We demonstrate that the subcutaneous infection model for secondary AE facilitates the assessment of the progress of infection and drug treatment in the live animal.

摘要

人体泡型包虫病(AE)是一种寄生虫病,其特征为肝脏严重受损,偶尔也会累及其他器官。AE 是由狐绦虫多房棘球蚴的囊尾蚴(幼虫)阶段感染引起的,通常以小型啮齿动物为天然中间宿主。传统上,人类 AE 采用苯并咪唑或阿苯达唑进行化学治疗。然而,仍然需要改进的化学治疗选择。对有兴趣的药物的初步体内研究通常在小型实验动物(如小鼠和蒙古沙鼠)中进行,在大多数情况下,使用二次感染模型,即将多房棘球蚴囊尾蚴直接注射到腹腔或肝脏中。这种方法的缺点包括接种过程中对器官造成损伤的风险,以及最显著的是,对治疗效果的宏观(可见)评估存在限制。因此,为了监测化学治疗的效果,必须对动物进行安乐死并解剖寄生虫组织。在本研究中,通过皮下途径感染小鼠多房棘球蚴囊尾蚴,然后用阿苯达唑进行化疗。通过比较感染的传统腹腔途径,评估了感染的血清学反应。我们证明,继发性 AE 的皮下感染模型有助于在活体动物中评估感染的进展和药物治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/4e5bf279d8aa/pntd.0002235.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/0308199b16cd/pntd.0002235.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/75a237bdf12a/pntd.0002235.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/f39cf28aeabf/pntd.0002235.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/4e5bf279d8aa/pntd.0002235.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/0308199b16cd/pntd.0002235.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/75a237bdf12a/pntd.0002235.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/f39cf28aeabf/pntd.0002235.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/3662659/4e5bf279d8aa/pntd.0002235.g004.jpg

相似文献

1
Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice.皮下感染模型有助于评估小鼠继发性泡型包虫病的治疗效果。
PLoS Negl Trop Dis. 2013 May 23;7(5):e2235. doi: 10.1371/journal.pntd.0002235. Print 2013.
2
Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.阿苯达唑联合百里酚对多房棘球绦虫原头节和中绦期幼虫的疗效。
Acta Trop. 2014 Dec;140:61-7. doi: 10.1016/j.actatropica.2014.08.007. Epub 2014 Aug 19.
3
In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.单独或与阿苯达唑联合使用的2-甲氧基雌二醇对细粒棘球绦虫幼虫的体外和体内作用
Exp Parasitol. 2008 Aug;119(4):475-482. doi: 10.1016/j.exppara.2008.02.012. Epub 2008 Mar 7.
4
In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.基于甲氟喹的治疗方案对细粒棘球蚴病的体内外疗效。
Antimicrob Agents Chemother. 2011 Feb;55(2):713-21. doi: 10.1128/AAC.01392-10. Epub 2010 Dec 6.
5
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.对开源疟疾药物盒的筛选发现了一种用于治疗肺泡型棘球蚴病的早期先导化合物。
PLoS Negl Trop Dis. 2016 Mar 11;10(3):e0004535. doi: 10.1371/journal.pntd.0004535. eCollection 2016 Mar.
6
Impact of Albendazole on Cytokine and Chemokine Response Profiles in -Inoculated Mice.阿苯达唑对感染小鼠细胞因子和趋化因子应答谱的影响。
Biomed Res Int. 2021 May 7;2021:6628814. doi: 10.1155/2021/6628814. eCollection 2021.
7
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.基于阿苯达唑-壳聚糖微球的治疗对小鼠肺泡型棘球蚴病的疗效
PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0003950. doi: 10.1371/journal.pntd.0003950. eCollection 2015.
8
Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.激酶抑制剂尼洛替尼和依维莫司对肺泡型棘球蚴病的体外及小鼠模型评价
Exp Parasitol. 2018 May;188:65-72. doi: 10.1016/j.exppara.2018.04.002. Epub 2018 Apr 3.
9
Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.泡型和囊型棘球蚴病的创新化疗治疗方案。
Parasitology. 2007 Nov;134(Pt 12):1657-70. doi: 10.1017/S0031182007003198. Epub 2007 Jul 16.
10
In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.阿苯达唑与百里酚联合应用对多房棘球绦虫的体内活性。
Vet Parasitol. 2015 Sep 15;212(3-4):193-9. doi: 10.1016/j.vetpar.2015.06.030. Epub 2015 Jul 10.

引用本文的文献

1
Establishment and application of unbiased in vitro drug screening assays for the identification of compounds against Echinococcus granulosus sensu stricto.建立和应用无偏体外药物筛选检测方法,以鉴定针对细粒棘球绦虫的化合物。
PLoS Negl Trop Dis. 2023 Aug 4;17(8):e0011343. doi: 10.1371/journal.pntd.0011343. eCollection 2023 Aug.
2
Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.阿苯达唑可减轻慢性泡状棘球蚴感染小鼠模型的肝炎症和内质网应激。
PLoS Negl Trop Dis. 2022 Jan 14;16(1):e0009192. doi: 10.1371/journal.pntd.0009192. eCollection 2022 Jan.
3

本文引用的文献

1
Voluntary ingestion of antiparasitic drugs emulsified in honey represents an alternative to gavage in mice.自愿摄取蜂蜜中乳化的抗寄生虫药物是小鼠灌胃给药的一种替代方法。
J Am Assoc Lab Anim Sci. 2012 Mar;51(2):219-23.
2
Curative effect of radiotherapy at various doses on subcutaneous alveolar echinococcosis in rats.不同剂量放疗对大鼠皮下泡型包虫病的疗效。
Chin Med J (Engl). 2011 Sep;124(18):2845-8.
3
In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.基于甲氟喹的治疗方案对细粒棘球蚴病的体内外疗效。
A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria.
一种新型钌基配位化合物抗致病菌。
Int J Mol Sci. 2020 Apr 10;21(7):2656. doi: 10.3390/ijms21072656.
4
The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.抗寄生虫作用的重要性……治疗泡型棘球蚴病药物研发的最新进展
Food Waterborne Parasitol. 2019 Mar 14;15:e00040. doi: 10.1016/j.fawpar.2019.e00040. eCollection 2019 Jun.
5
T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model.在细粒棘球蚴清除过程中的 T 细胞耐受和耗竭:接种量在定量肝实验模型中的作用。
Sci Rep. 2017 Sep 11;7(1):11153. doi: 10.1038/s41598-017-11703-1.
6
Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.阿苯达唑可增强人类肝泡型包虫病病变中多房棘球绦虫(spems)的炎症反应及Em2阳性小颗粒数量。
PLoS Negl Trop Dis. 2017 May 25;11(5):e0005636. doi: 10.1371/journal.pntd.0005636. eCollection 2017 May.
7
Evaluation of the Metabolic Activity of Echinococcus multilocularis in Rodents Using Positron Emission Tomography Tracers.使用正电子发射断层显像示踪剂评估啮齿动物体内多房棘球绦虫的代谢活性
Mol Imaging Biol. 2015 Aug;17(4):512-20. doi: 10.1007/s11307-014-0815-3.
8
On the importance of targeting parasite stem cells in anti-echinococcosis drug development.靶向寄生虫干细胞在抗包虫病药物研发中的重要性
Parasite. 2014;21:72. doi: 10.1051/parasite/2014070. Epub 2014 Dec 22.
9
Treatment of echinococcosis: albendazole and mebendazole--what else?棘球蚴病的治疗:阿苯达唑和甲苯达唑——还有其他的吗?
Parasite. 2014;21:70. doi: 10.1051/parasite/2014073. Epub 2014 Dec 22.
10
Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1.通过抑制多房棘球绦虫干细胞中的 Polo 样激酶 EmPlk1 来靶向多房棘球绦虫干细胞。
PLoS Negl Trop Dis. 2014 Jun 5;8(6):e2870. doi: 10.1371/journal.pntd.0002870. eCollection 2014 Jun.
Antimicrob Agents Chemother. 2011 Feb;55(2):713-21. doi: 10.1128/AAC.01392-10. Epub 2010 Dec 6.
4
Quantitative studies on the latent period of tumors induced with subcutaneous injections of the agent of chicken tumor I; estimation of the latent period.鸡肿瘤I因子皮下注射诱导肿瘤潜伏期的定量研究;潜伏期的估计。
J Natl Cancer Inst. 1946 Jun;6:373-7.
5
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.《包虫病(棘球蚴病、包虫病)临床诊断与治疗专家共识(2023 版)》
Acta Trop. 2010 Apr;114(1):1-16. doi: 10.1016/j.actatropica.2009.11.001. Epub 2009 Nov 30.
6
Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.细粒棘球蚴囊尾蚴作为筛选抗绦虫和吸虫药物的实验室模型。
Parasitology. 2010 Mar;137(3):569-87. doi: 10.1017/S003118200999117X. Epub 2009 Sep 21.
7
Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options.肺泡型和囊型棘球蚴病:探索新型化疗治疗方案
J Helminthol. 2009 Jun;83(2):99-111. doi: 10.1017/S0022149X0928936X. Epub 2009 Mar 19.
8
Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?用于治疗囊型和泡型棘球蚴病的苯并咪唑类药物:共识是什么?
Expert Rev Anti Infect Ther. 2009 Mar;7(2):145-9. doi: 10.1586/14787210.7.2.145.
9
Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures.多房棘球绦虫囊尾蚴泡的无菌体外培养及原代细胞培养的建立
Methods Mol Biol. 2009;470:245-62. doi: 10.1007/978-1-59745-204-5_17.
10
In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.单独或与阿苯达唑联合使用的2-甲氧基雌二醇对细粒棘球绦虫幼虫的体外和体内作用
Exp Parasitol. 2008 Aug;119(4):475-482. doi: 10.1016/j.exppara.2008.02.012. Epub 2008 Mar 7.